NO960250L - Nye mercaptoalkanoyldipeptidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye mercaptoalkanoyldipeptidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO960250L
NO960250L NO960250A NO960250A NO960250L NO 960250 L NO960250 L NO 960250L NO 960250 A NO960250 A NO 960250A NO 960250 A NO960250 A NO 960250A NO 960250 L NO960250 L NO 960250L
Authority
NO
Norway
Prior art keywords
radical
straight
branched chain
carbon atoms
group
Prior art date
Application number
NO960250A
Other languages
English (en)
Norwegian (no)
Other versions
NO960250D0 (no
Inventor
Bernard Pierre Roques
Marie-Claude Fournie-Zaluski
Original Assignee
Adir
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir, Inst Nat Sante Rech Med filed Critical Adir
Publication of NO960250D0 publication Critical patent/NO960250D0/no
Publication of NO960250L publication Critical patent/NO960250L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO960250A 1995-01-23 1996-01-22 Nye mercaptoalkanoyldipeptidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO960250L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500694A FR2729668A1 (fr) 1995-01-23 1995-01-23 Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO960250D0 NO960250D0 (no) 1996-01-22
NO960250L true NO960250L (no) 1996-07-24

Family

ID=9475379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960250A NO960250L (no) 1995-01-23 1996-01-22 Nye mercaptoalkanoyldipeptidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (17)

Country Link
US (1) US5741781A (de)
EP (1) EP0723974B1 (de)
JP (1) JPH08325290A (de)
CN (1) CN1137040A (de)
AT (1) ATE204293T1 (de)
AU (1) AU699204B2 (de)
CA (1) CA2167763A1 (de)
DE (1) DE69614417T2 (de)
DK (1) DK0723974T3 (de)
ES (1) ES2162986T3 (de)
FI (1) FI960284L (de)
FR (1) FR2729668A1 (de)
GR (1) GR3037041T3 (de)
NO (1) NO960250L (de)
NZ (1) NZ280870A (de)
PT (1) PT723974E (de)
ZA (1) ZA96516B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729668A1 (fr) * 1995-01-23 1996-07-26 Adir Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
RU2245147C2 (ru) * 1999-03-29 2005-01-27 Бристол-Маерс Сквибб Компани Применение ингибитора вазопептидазы для лечения стенокардии
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
SG176009A1 (en) * 2009-05-28 2011-12-29 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3272505D1 (en) * 1981-03-09 1986-09-18 Merck & Co Inc Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
US4560506A (en) * 1984-05-25 1985-12-24 E. R. Squibb & Sons, Inc. Mercaptocycloalkylcarbonyl and mercaptoarylcarbonyl dipeptides
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
WO1994017036A1 (en) * 1993-01-22 1994-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) S-lipophilic aliphatic carbonyl [n-mercaptoacyl-(amino acid or peptide)] compounds as antihypertensive agents
FR2729668A1 (fr) * 1995-01-23 1996-07-26 Adir Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ZA96516B (en) 1996-08-15
AU699204B2 (en) 1998-11-26
ES2162986T3 (es) 2002-01-16
GR3037041T3 (en) 2002-01-31
EP0723974A1 (de) 1996-07-31
US5741781A (en) 1998-04-21
NO960250D0 (no) 1996-01-22
DE69614417T2 (de) 2002-05-29
ATE204293T1 (de) 2001-09-15
FR2729668A1 (fr) 1996-07-26
AU4210196A (en) 1996-08-01
CA2167763A1 (fr) 1996-07-24
FI960284A7 (fi) 1996-07-24
DE69614417D1 (de) 2001-09-20
CN1137040A (zh) 1996-12-04
FI960284L (fi) 1996-07-24
DK0723974T3 (da) 2001-10-08
JPH08325290A (ja) 1996-12-10
EP0723974B1 (de) 2001-08-16
PT723974E (pt) 2001-11-30
NZ280870A (en) 1997-09-22
FR2729668B1 (de) 1997-02-21
FI960284A0 (fi) 1996-01-19

Similar Documents

Publication Publication Date Title
NO940550L (de)
IS2833B (is) 1,5 Bensóþíósepín og notkun þeirra gegn fitublæði
MC225A7 (fr) 2-(2,6-Dioxopiperidine-3-yl)-phtalimides et-1-oxo-iso-indolines substitutes et methodes pour reduireles taux de tnf-alpha
DK0698010T3 (da) N-acylsulfaminsyreestere (eller thioestere), N-acylsulfonamider og N-sulfonylcarbaminsyreestere (eller thioestere) som hype
MX9101280A (es) Compuestos inhibidores de la trombina y composicion farmaceutica que los contiene
ES2126500A1 (es) Fotoiniciadores de borato a partir de monoboranos.
NO20045099L (no) Peptid-derivater omfattende tiazepingruppen for behandling av hyperlipidemiske tilstander
DK345285A (da) Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DE69521500D1 (de) Phosphorsäurediester-derivate
HUP0002942A2 (hu) Szerin proteáz inhibitor hatású peptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
NO20024217D0 (no) 1,5-benzotiazepiner og deres anvendelse som hypolipidmidler
NO993868L (no) 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme
DK142084D0 (da) N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf
ZA81140B (en) Pyrimidine-2-sulphides and their s-oxides for use in medicine and methods of use therefor,pharmaceutical compositions containing them,processes for their preparation and such compounds when novel per se
NO960250L (no) Nye mercaptoalkanoyldipeptidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO944926L (no) Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO961000L (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
MXPA02001651A (es) Inhibicion de la polimerizacion de monomeros etilenicamente no saturados.
NO20023251L (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
HUP9900679A2 (hu) Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20000434L (no) Lyksofuranosyl benzimidazoler som antivirale midler
DK0672043T3 (da) Hidtil ukendte 4-(3-benzofuranyl)-piperidinyl- og 4-(3-benzothienyl)-piperidinyl-derivater og farmaceutiske præparater indeholdende dem
NO992316L (no) Benzensulfonamidderivater og legemidler inneholdende disse
YU13003A (sh) Prolekovi za ligande nmda receptora

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application